An inflammatory cytokine signature predicts COVID-19 severity and survivalDiane M. Del Valle, Sacha Gnjatic, Hui Xie et al.|Nature Medicine|2020Cited by 2.7k
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myelomaOliver Van Oekelen, Samir Parekh, Charles Gleason et al.|Cancer Cell|2021Cited by 216
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapyOliver Van Oekelen, Samir Parekh, Karthik Nath et al.|Blood|2022Cited by 103
A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myelomaAjai Chari, Samir Parekh|Blood Advances|2017Cited by 60
Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patientsAdolfo Aleman, Samir Parekh, Oliver Van Oekelen et al.|Cancer Cell|2022Cited by 38